University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA
Tel: (+44) (0)114 222 0745
Fax: +44 (0)114 222 0749
I joined ScHARR as a Research Fellow in May 2017. Prior to this I worked as a Technical Adviser at the National Institute for Health and Care Excellence (NICE) leading methodological research projects and economic evaluations for public health and social care guidelines. Before joining NICE I worked as a Principal Health Economist in a consultancy developing economic models and submissions for health technology assessment. Whilst working in consultancy I completed my MSc in Health Economics and Decision Modelling at The University of Sheffield. I have a BSc in Mathematics from The University of Sheffield.
I work as a health economic modeller on projects for the Decision Support Unit.
Pennington B, Akehurst R, Wasan H, Sangro B, Kennedy AS, Sennfält K, Bester L. Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK. J Med Econ. 2015 Jun 9:1-8.
Pennington B, Davis S. Mapping from the Health Assessment Questionnaire to the EQ-5D: The Impact of Different Algorithms on Cost-Effectiveness Results. Value Health. 2014; 17(8):762-71.
Hatswell AJ, Pennington B, Pericleous L, Rowen D, Lebmeier M, Lee D. Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death. Health Qual Life Outcomes. 2014 Sep 10;12(1):140.
Brereton N, Pennington B, Ekelund M, Akehurst R. A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model. J Med Econ. 2014 Sep;17(9):677-84.
Batty AJ, Hansen R, Bloudek L, Varon S, Hayward E, Pennington B, Lipton R, Sullivan S. The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK. J Med Econ. 2013 Jul;16(7):877-87